JP-2266

Cat. No. M31403

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

JP-2266 is a dual SGLT1/2 inhibitor that can be used in studies related to diabetes.

Storage

Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month

Related SGLT Products
Velagliflozin Velagliflozin is an orally available sodium-glucose cotransporter 2 (SGLT2) inhibitor, with anti-diabetic activity.
Tianagliflozin Tianagliflozin is an SGLT2 inhibitor that may be used in studies related to type 2 diabetes.
JTT-662 JTT-662 is an SGLT1 inhibitor that can be used in studies related to type 2 diabetes.
Tofogliflozin Tofogliflozin(CSG-452) is a potent and highly specific sodium/glucose cotransporter 2(SGLT2) inhibitor with Ki values of 2.9, 14.9, and 6.4 nM for human, rat, and mouse SGLT2.
Mizagliflozin Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a Ki of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation.

Catalog